Beckman To Buy Biosite

Biomedical laboratory instrument maker Beckman Coulter Inc. (BEC) offered $1.55 billion to buy Biosite Inc. (BSTE). Shares of Biosite leaped $28.42 to close at $83.80 while Beckman stock plunged $4.57 to close at $62.51.